UCLE · As filed with the SEC
US Nuclear cash flow statement, by fiscal year
The statement as US Nuclear presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| OPERATING ACTIVITIES | ||||
| Net loss | (1,239,051) | (1,739,926) | (3,433,804) | (2,042,795) |
| Adjustment to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | 1,440 | 2,253 | 3,141 | 3,218 |
| Bad debt expense | — | — | 6,590 | — |
| IRS Penalties | — | — | 117,154 | — |
| Issuance of common stock for compensation | 56,100 | — | — | — |
| Issuance of warrants for services | 524,250 | 204,311 | 454,165 | 267,246 |
| Amortization of debt discounts | — | — | 1,347,070 | 482,852 |
| Finance costs | — | — | — | 8,750 |
| Issuance of common stock warrants for debt | 8,334 | — | — | — |
| Finance costs | — | 92,500 | 197,643 | — |
| Loss on deconsolidation | — | — | 2,539 | — |
| Loss on investment deposit | — | — | 15,000 | — |
| Loss on extinguishment of debt | — | — | 79,646 | — |
| Loss on conversion of stock | — | — | 32,710 | — |
| Equity loss in investment | — | — | 8,059 | — |
| Incentive expense | 24,000 | — | — | — |
| Goodwill impairment | 130,514 | — | — | — |
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | 137,698 | (9,227) | (18,904) | (166,281) |
| Note receivable | 1,950 | — | — | — |
| Inventories | 452,931 | 225,768 | 262,881 | (232,352) |
| Prepaid expenses and other current assets | — | — | — | (12,620) |
| Prepaid expenses and other current assets | — | — | 26,370 | — |
| Accounts payable | — | — | 107,531 | — |
| Prepaid expenses and other current assets | 4,370 | — | — | — |
| Accounts payable | (38,836) | 48,347 | — | 8,539 |
| Accounts payable - related parties | — | 144,000 | 176,000 | 151,500 |
| Accrued liabilities | 43,009 | 69,720 | 218,110 | 115,532 |
| Accrued compensation - officers | — | — | — | 105,000 |
| Accrued compensation - officers | — | 88,000 | 165,000 | — |
| Deferred revenue | — | 76,949 | — | — |
| Customer deposits | — | 288,252 | — | — |
| Customer deposits | (306,052) | — | (81,923) | (12,648) |
| Deferred revenue | — | — | 51,578 | — |
| Net cash used in operating activities | (199,343) | (509,053) | (263,444) | (1,324,059) |
| INVESTING ACTIVITIES | ||||
| Purchase of property and equipment | — | — | (858) | — |
| Employee advance | — | (10,000) | — | — |
| Note receivable | — | (20,767) | (21,149) | — |
| Cash paid for investment | — | — | (2,539) | — |
| Net cash used in investing activities | — | (30,767) | (24,546) | — |
| FINANCING ACTIVITIES | ||||
| Net borrowings (repayments) under lines of credit | 74,857 | — | 3,952 | 26,149 |
| Proceeds from note payable shareholder | 79,019 | — | — | — |
| Repayments of note payable shareholder | (81,201) | (155,868) | (86,600) | (6,214) |
| Proceeds from convertible note payable | 75,000 | 144,000 | — | 916,500 |
| Repayments of convertible note payable | — | (200,000) | (129,565) | — |
| Proceeds from note payable to shareholder | — | — | 432,200 | 304,633 |
| Proceeds from note payable to shareholder | — | 531,100 | — | — |
| Proceeds from notes payable | 264,000 | 249,400 | 122,501 | — |
| Repayments of notes payable | (221,568) | (178,812) | (27,767) | (37,217) |
| Retirement of common stock | (7,425) | — | — | — |
| Proceeds from issuance of common stock | 50,000 | — | — | — |
| Proceeds from issuance of preferred stock | — | 128,000 | — | — |
| Cash dividends paid | (29,400) | — | — | — |
| Net cash provided by financing activities | 203,282 | 517,820 | 314,721 | 1,203,851 |
| NET INCREASE (DECREASE) IN CASH | 3,939 | (22,000) | 26,731 | (120,208) |
| CASH | ||||
| Beginning of period | 130,840 | 152,840 | 126,109 | 246,317 |
| End of period | 134,779 | 130,840 | 152,840 | 126,109 |
| Supplemental disclosures of cash flow information | ||||
| Interest paid | 164,860 | 61,553 | 20,435 | 11,973 |
| Dividends paid | 29,400 | — | — | — |
| Non-Cash investing and financing activities | ||||
| Additional principal as consideration of maturity date extension | — | 92,500 | 912,248 | 239,044 |
| Common shares issued for future services | — | — | — | 39,000 |
| Common shares issued for future services | — | — | 126,000 | — |
| Conversion of convertible notes | 406,456 | 371,780 | 351,890 | — |
| Preferred stock issued for conversion of debt | — | 1,878,000 | — | — |
| Preferred stock dividends payable in common stock | — | 45,813 | — | — |
| Preferred stock issued for settlement of notes payable | 650,000 | — | — | — |
| Preferred stock dividends payable in common stock | 104,248 | 28,633 | — | — |
| Preferred stock dividends payable in cash | 130,190 | — | — | — |
| Warrants issued for debt and services | 532,584 | — | — | — |
| Accrued compensation in exchange for notes payable | — | 500,000 | — | — |
| Deemed dividend on down round provision | — | — | 2,013 | 17,924 |
| Common stock issued for conversion of convertible debt and accrued interest | — | — | — | 260,000 |
| Original issue debt discount | — | — | — | 751,026 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.